Pharmaceutical companies are facing mounting pressure to streamline their global labeling operations, which can be a risky and costly full-scale transformation. A targeted pilot provides a strategic, low-risk way to uncover current state gaps. Most importantly, it validates how emerging technologies like component-based authoring and generative AI can close those gaps. By offering stakeholders clear insights into future-state workflows, a pilot ensures the organization is fully prepared for a scalable, global rollout.
Why Start with a Pilot?
A pilot provides the opportunity to:
- Identify inefficiencies in current workflows
- Demonstrate how technology can close gaps
- Validate outcomes before scaling globally
- Build stakeholder confidence in the future-state solution
Identifying Inefficiencies and Measuring ROI
One of the first outcomes of a pilot is the ability to expose inefficiencies in current labeling operations. Fragmented document management systems, inconsistent templates, and manual publishing workflows often drain time and increase risk. Documenting these challenges is critical—not just to justify change, but to translate them into a quantifiable return on investment (ROI).
By capturing metrics around time saved, error reduction, and improved compliance, the pilot equips decision-makers with hard data. This evidence strengthens the business case and provides a clear picture of the value a global labeling transformation can deliver.
Mapping Current to Future-State Workflows
The most effective pilots don’t stay theoretical. Instead, they simulate mock-production scenarios that mirror day-to-day labeling activities. This practical approach highlights exactly how future workflows will look and where efficiencies are gained.
For example, pilots can test structured publishing outputs like FHIR, showing how they can be configured and validated in practice. They also establish realistic boundaries—clarifying what technology can automate versus what still requires human review. This helps organizations avoid overpromising and ensures compliance and quality remain intact.
Harnessing Generative AI for Structured Authoring
Generative AI introduces new possibilities for structured content authoring. During the pilot phase, teams can test how AI models trained on industry standards and regulatory data parse legacy documents and create draft modular components. Fine-tuning with company-specific precedents takes this a step further, enabling rapid, consistent, regulator-ready authoring.
Importantly, pilots also provide a safe environment to refine prompt engineering and validate AI outputs. By stress-testing scenarios, organizations ensure that AI-generated content not only meets compliance standards but also aligns with their voice, style, and risk profile.
RELATED: Generative AI: Transforming Pharmaceutical Content Authoring for the Better
Aligning Technology with Business Needs
A pilot is not just about testing systems, it’s about ensuring they support the business. Bringing together regulatory, labeling, IT, and quality teams allows organizations to evaluate broader needs such as training, change management, and cross-market adaptation.
This stage often reveals whether solutions can manage local nuances, track component versioning, maintain audit trails, and support multi-language outputs. Addressing these business-critical requirements early helps ensure the technology is not only functional but fit for purpose on a global scale.
Building the Business Case for Transformation
The final outcome of a pilot is a solid foundation for transformation. By providing measurable results, demonstrating cross-team alignment, and confirming readiness to scale, the pilot reduces risk while strengthening the case for investment.
As the industry shifts toward standards like FHIR and IDMP, the need for future-ready platforms that combine structured content with AI capabilities is no longer optional; it’s essential. A thoughtfully executed pilot ensures organizations can meet these demands with confidence, clarity, and a roadmap for success.
Take the Next Step
A global labeling transformation begins with a well-designed pilot. By starting small, organizations gain the clarity they need to scale successfully—minimizing risk while maximizing impact across global markets.
Ready to see how a thoughtfully executed pilot can transform your global labeling operations? Contact Glemser today to learn how we can help you optimize workflows, implement structured content, and leverage generative AI for scalable, compliant, and future-ready labeling.